Powerful, Controversial Pain Killer Gets FDA Approval

,

Lawmakers in Massachusetts have blocked sales of Zogenix’s controversial painkiller Zohydro.

According to Reuters, the drug has been plagued with controversy, as some advocates say that it could lead to a wave of opioid abuse among users. The drug is part of a powerful class of painkillers.

The drug is an extended-release form of hydrocodone that does not contain acetaminophen. If the drug is linked to complications following its release nationally, Zogenix should be held liable.

Last year, a Food and Drug Administration (FDA) advisory panel expressed concerns about the potential for abuse relating to the drug.

Sponsored by Zoll, Kranz & Brogess, LLC, serving clients nationwide.

0 replies
Want to join the discussion?
Feel free to contribute!

Leave a Reply